The pharmaceutical landscape is seeing a change with the emergence of GLP-1 delivery devices. These exciting formulations offer a potential alternative to providing glucagon-like peptide-1 drugs for individuals living with the disease . Instead of daily shots , a simple patch affixed to the skin